| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13137* | 2021 |
| Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma SM Lin, ML Yu, CM Lee, RN Chien, IS Sheen, CM Chu, YF Liaw Journal of hepatology 46 (1), 45-52, 2007 | 485 | 2007 |
| A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C ML Yu, CY Dai, JF Huang, NJ Hou, LP Lee, MY Hsieh, CF Chiu, ZY Lin, ... Gut 56 (4), 553-559, 2007 | 359 | 2007 |
| Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: a randomized trial ML Yu, CY Dai, JF Huang, CF Chiu, YHC Yang, NJ Hou, LP Lee, ... Hepatology 47 (6), 1884-1893, 2008 | 341 | 2008 |
| Treatment of chronic hepatitis C in Asia: when East meets West ML Yu, WL Chuang Journal of gastroenterology and hepatology 24 (3), 336-345, 2009 | 338 | 2009 |
| APASL consensus statements and recommendation on treatment of hepatitis C M Omata, T Kanda, L Wei, ML Yu, WL Chuang, A Ibrahim, CRA Lesmana, ... Hepatology international 10, 702-726, 2016 | 241 | 2016 |
| APASL consensus statements and management algorithms for hepatitis C virus infection M Omata, T Kanda, ML Yu, O Yokosuka, SG Lim, W Jafri, R Tateishi, ... Hepatology International 6, 409-435, 2012 | 238 | 2012 |
| Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses CJ Liu, WL Chuang, CM Lee, ML Yu, SN Lu, SS Wu, LY Liao, CL Chen, ... Gastroenterology 136 (2), 496-504. e3, 2009 | 230 | 2009 |
| A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre … ML Yu, SM Lin, WL Chuang, CY Dai, JH Wang, SN Lu, IS Sheen, ... Antiviral therapy 11 (8), 985-994, 2006 | 228 | 2006 |
| Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients ML Yu, CF Huang, JF Huang, NC Chang, JF Yang, ZY Lin, SC Chen, ... Hepatology 53 (1), 7-13, 2011 | 216 | 2011 |
| Significant correlations between severe fatty liver and risk factors for metabolic syndrome PJ Hsiao, KK Kuo, SJ Shin, YH Yang, WY Lin, JF Yang, CC Chiu, ... Journal of gastroenterology and hepatology 22 (12), 2118-2123, 2007 | 193 | 2007 |
| Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis CW Lin, CC Lin, LR Mo, CY Chang, DS Perng, CC Hsu, GH Lo, YS Chen, ... Journal of hepatology 58 (4), 730-735, 2013 | 187 | 2013 |
| Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ... Cancer cell 30 (6), 879-890, 2016 | 186 | 2016 |
| Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients CY Dai, JF Huang, MY Hsieh, NJ Hou, ZY Lin, SC Chen, MY Hsieh, ... Journal of hepatology 50 (4), 712-718, 2009 | 182 | 2009 |
| Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study CY Dai, WL Chuang, CK Ho, MY Hsieh, JF Huang, LP Lee, NJ Hou, ... Journal of hepatology 49 (1), 9-16, 2008 | 177 | 2008 |
| Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis MM Mücke, LI Backus, VT Mücke, N Coppola, CM Preda, ML Yeh, ... The Lancet Gastroenterology & Hepatology 3 (3), 172-180, 2018 | 176 | 2018 |
| Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication JF Huang, CY Dai, SJ Hwang, CK Ho, PJ Hsiao, MY Hsieh, LP Lee, ... Official journal of the American College of Gastroenterology| ACG 102 (6 …, 2007 | 168 | 2007 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 164 | 2022 |
| Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement GLH Wong, VWS Wong, A Thompson, J Jia, J Hou, CRA Lesmana, ... The Lancet Gastroenterology & Hepatology 5 (8), 776-787, 2020 | 153 | 2020 |
| Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis JJ Lee, MY Lin, JS Chang, CC Hung, JM Chang, HC Chen, ML Yu, ... PloS one 9 (6), e100790, 2014 | 141 | 2014 |
Meng-Hsuan HsiehKaohsiung Medical University HospitalVerified email at cc.kmu.edu.tw
